Abstract
Benzimidazole derivatives play an important role in medical field with so many Pharmacological activities, such as selective neuropeptides YY1 receptor antagonists, gamma-amino butyric acid (GABA) agonists, and 5-HT3 antagonists, anticonvulsant and other activities encouraged the development of some more potent and significant compounds. This review presents different substituted benzimidazole derivatives which possess potential along central acting activity.
Keywords: Anticonvulsant, benzimidazole derivatives, sedative hypnotics, serotoninergic agents.
Current Drug Therapy
Title:Benzimidazole Derivatives as Centerally Acting Agents
Volume: 8 Issue: 3
Author(s): Hassan Y. Aboul-Enein and Ahmed A. El Rashedy
Affiliation:
Keywords: Anticonvulsant, benzimidazole derivatives, sedative hypnotics, serotoninergic agents.
Abstract: Benzimidazole derivatives play an important role in medical field with so many Pharmacological activities, such as selective neuropeptides YY1 receptor antagonists, gamma-amino butyric acid (GABA) agonists, and 5-HT3 antagonists, anticonvulsant and other activities encouraged the development of some more potent and significant compounds. This review presents different substituted benzimidazole derivatives which possess potential along central acting activity.
Export Options
About this article
Cite this article as:
Y. Aboul-Enein Hassan and A. El Rashedy Ahmed, Benzimidazole Derivatives as Centerally Acting Agents, Current Drug Therapy 2013; 8 (3) . https://dx.doi.org/10.2174/1574885508999131119120237
DOI https://dx.doi.org/10.2174/1574885508999131119120237 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Management of Huntingtons Disease: An Evidence- Based Review
Current Pharmaceutical Design New Perspectives on the Structure and Function of the Na+ Channel Multigene Family
Current Medicinal Chemistry - Central Nervous System Agents Annexins in the Central Nervous System: Are they Neuroprotective or Proapoptotic Agents?
Medicinal Chemistry Reviews - Online (Discontinued) Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Current Neuropharmacology Transitional Polytherapy: Tricks of the Trade for Monotherapy to Monotherapy AED Conversions
Current Neuropharmacology Global Cerebral Ischemia: Synaptic and Cognitive Dysfunction
Current Drug Targets Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Synthesis and Evaluation of Phenyliminoindolin-Containing Phenylacetamide Derivatives with the Antidepressant and Anticonvulsant Effects
Medicinal Chemistry Area, Age and Gender Dependence of the Nucleoside System in the Brain: a Review of Current Literature
Current Topics in Medicinal Chemistry Sugar-Borate Esters – Potential Chemical Agents in Prostate Cancer Chemoprevention
Anti-Cancer Agents in Medicinal Chemistry Editorial [Hot topic: Immunological Regulation of the Central Nervous System: From Physiological to Pathological Processes (Guest Editor: Oscar Gonzalez-Perez)]
Current Immunology Reviews (Discontinued) Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Bifrontal ECT: A Systematic Review and Meta-Analysis of Efficacy and Cognitive Impact
Current Psychiatry Reviews Endophenotypes and Biological Markers of Schizophrenia: From Biological Signs of Illness to Novel Treatment Targets
Current Pharmaceutical Design Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
Current Pharmaceutical Design Increased Risk of Falls, Fall-related Injuries and Fractures in People with Type 1 and Type 2 Diabetes - A Nationwide Cohort Study
Current Drug Safety Organic Lesions in the Brain MRI of Children with Febrile Seizure
Current Medical Imaging On the Discovery and Development of CFTR Chloride Channel Activators
Current Pharmaceutical Design Adenosine Neuromodulation and Traumatic Brain Injury
Current Neuropharmacology Exogenous Progesterone: A Potential Therapeutic Candidate in CNS Injury and Neurodegeneration
Current Medicinal Chemistry